A PHASE-II STUDY OF HIGH-DOSE CISPLATIN AND VP-16 IN NEUROBLASTOMA - A REPORT FROM THE SOCIETE-FRANCAISE-DONCOLOGIE-PEDIATRIQUE

被引：78

作者：

PHILIP, T

GHALIE, R

PINKERTON, R

ZUCKER, JM

BERNARD, JL

LEVERGER, G

HARTMANN, O

机构：

[1] HOP TIMONE,DEPT PEDIAT ONCOL,MARSEILLE,FRANCE

[2] INST GUSTAVE ROUSSY,DEPT PEDIAT ONCOL,F-94805 VILLEJUIF,FRANCE

[3] INST CURIE,DEPT PEDIAT ONCOL,F-75231 PARIS 05,FRANCE

[4] HOP ST LOUIS,F-75475 PARIS 10,FRANCE

来源：

关键词：

D O I：

10.1200/JCO.1987.5.6.941

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：941 / 950

页数：10

共 45 条

[1] DETECTION OF BONE-MARROW INVOLVEMENT BY NEURO-BLASTOMA - COMPARISON OF 2 CYTOLOGICAL METHODS
BAYLE, C
ALLARD, T
RODARY, C
VANDERPLANCKE, J
HARTMANN, O
LEMERLE, J
[J]. EUROPEAN PAEDIATRIC HAEMATOLOGY AND ONCOLOGY, 1985, 2 (03): : 123 - 128
[2] BERNARD JL, 1986, UNPUB J CLIN ONCOL
[3] EARLY CLINICAL-STUDIES WITH CIS-DIAMMINE-1,1-CYCLOBUTANE DICARBOXYLATE PLATINUM-II
CALVERT, AH
HARLAND, SJ
NEWELL, DR
SIDDIK, ZH
JONES, AC
MCELWAIN, TJ
RAJU, S
WILTSHAW, E
SMITH, IE
BAKER, JM
PECKHAM, MJ
HARRAP, KR
[J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 9 (03) : 140 - 147
[4] CHARD RL, 1979, CANCER TREAT REP, V63, P1755
[5] CLINICAL-PHARMACOLOGY OF HIGH-DOSE CISPLATIN
CORDEN, BJ
FINE, RL
OZOLS, RF
COLLINS, JM
[J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1985, 14 (01) : 38 - 41
[6] EARHART RH, 1983, CANCER RES, V43, P1187
[7] EVANS AE, 1971, CANCER, V27, P374, DOI 10.1002/1097-0142(197102)27:2<374::AID-CNCR2820270221>3.0.CO
[8] 2-G
[9] EVANS WE, 1982, CANCER CHEMOTH PHARM, V7, P147
[10] FAUSTI SA, 1984, CANCER, V53, P224, DOI 10.1002/1097-0142(19840115)53:2<224::AID-CNCR2820530207>3.0.CO